quinazolines has been researched along with Primary Peritonitis in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burda, WN; Fleeman, R; Manetsch, R; Shaw, LN; Van Horn, KS | 1 |
| Barber, MM; Burda, WN; Flanigan, DL; Fleeman, R; Manetsch, R; Shaw, LN; Van Horn, KS | 1 |
| Altenbach, RJ; Brioni, JD; Carr, TL; Chandran, P; Cowart, MD; Esbenshade, TA; Honore, P; Hsieh, GC; Lewis, LG; Liu, H; Manelli, AM; Marsh, KC; Milicic, I; Miller, TR; Strakhova, MI; Vortherms, TA; Wakefield, BD; Wetter, JM; Witte, DG | 1 |
| Asano, H; Harada, M; Kagawa, S; Kanazawa, S; Katsui, K; Maki, Y; Masuda, H; Miyoshi, S; Muraoka, T; Naito, M; Naomoto, Y; Takemoto, M; Toyooka, S; Tsukuda, K | 1 |
| Teh, BW; Worth, LJ | 1 |
| Malaviya, R; Navara, C; Uckun, FM | 1 |
| Nakata, H; Ohsaki, Y; Tuji, T | 1 |
| Fukuda, Y; Goto, M; Terakawa, M; Tomimori, Y | 1 |
| Caruso, A; Cutuli, VM; Mangano, NG; Modica, M; Santagati, A; Santagati, M | 1 |
| Caruso, A; Catena Cutuli, VM; Daidone, G; Maggio, B; Mangano, NG; Mantione, L; Plescia, S; Raffa, D | 1 |
| Awata, H; Inaba, S; Saito, C; Yamamoto, H; Yamamoto, M | 1 |
11 other study(ies) available for quinazolines and Primary Peritonitis
| Article | Year |
|---|---|
Antibacterial activity of a series of N2,N4-disubstituted quinazoline-2,4-diamines.
Topics: Animals; Anti-Bacterial Agents; Diamines; Disease Models, Animal; Hemolysis; Humans; Larva; Microbial Sensitivity Tests; Molecular Structure; Peritonitis; Quinazolines; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship | 2014 |
Characterizing the Antimicrobial Activity of
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Biofilms; Cell Line, Tumor; Cell Survival; Diamines; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Folic Acid Antagonists; Hep G2 Cells; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Peritonitis; Quinazolines; Tetrahydrofolate Dehydrogenase | 2017 |
cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzofurans; Carrageenan; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Humans; Hyperalgesia; Ligands; Mice; Molecular Structure; Pain; Peritonitis; Quinazolines; Rats; Receptors, G-Protein-Coupled; Receptors, Histamine; Receptors, Histamine H4; Stereoisomerism; Structure-Activity Relationship | 2008 |
Ileal perforation induced by acute radiation injury under gefitinib treatment.
Topics: Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Enteritis; ErbB Receptors; Female; Gefitinib; Humans; Intestinal Mucosa; Intestine, Small; Lung Neoplasms; Peritonitis; Quinazolines; Radiation Injuries; Radiotherapy; Wound Healing | 2011 |
Disseminated herpes simplex virus infection following epidermal growth factor tyrosine kinase inhibitor therapy for non-small-cell lung carcinoma.
Topics: Acyclovir; Afatinib; Aged; Antineoplastic Agents; Antiviral Agents; Carcinoma, Non-Small-Cell Lung; Cystitis; ErbB Receptors; Esophagitis; Hematuria; Herpes Simplex; Humans; Intestinal Perforation; Lung Neoplasms; Male; Molecular Targeted Therapy; Neoplasm Proteins; Peritonitis; Protein Kinase Inhibitors; Quinazolines; Valacyclovir; Valine; Viremia; Virus Activation | 2012 |
Augmentation of mast cell bactericidal activity by the anti-leukemic drug, 4-(3'bromo-4'-hydroxylphenyl)-amino-6,7-dimethoxyquinazoline.
Topics: Adjuvants, Immunologic; Animals; Cells, Cultured; Drug Evaluation, Preclinical; Escherichia coli; Escherichia coli Infections; Male; Mast Cells; Mice; Mice, Inbred BALB C; Peritonitis; Phagocytosis; Quinazolines; Specific Pathogen-Free Organisms | 2002 |
[A case of peritonitis carcinomatosa of pulmonary adenocarcinoma in which gefitinib was effective].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Agents; Ascitic Fluid; Gefitinib; Humans; Lung Neoplasms; Male; Middle Aged; Peritoneal Neoplasms; Peritonitis; Quinazolines | 2004 |
Mast cell chymase induces expression of chemokines for neutrophils in eosinophilic EoL-1 cells and mouse peritonitis eosinophils.
Topics: Animals; Butadienes; Cell Line, Tumor; Chemokine CXCL2; Chemokines; Chymases; Cytokines; Dose-Response Relationship, Drug; Enzyme Inhibitors; Eosinophils; Gene Expression; Humans; Imidazoles; Interleukin-8; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; Neutrophils; Nitriles; Peritonitis; Pertussis Toxin; Pyridines; Quinazolines; RNA, Messenger; Serine Endopeptidases | 2006 |
Synthesis and pharmacological screening of 1,3,4-thiadiazino[2,3-b]quinazoline derivatives.
Topics: Acetic Acid; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Carrageenan; Edema; Lethal Dose 50; Male; Mice; Pain Measurement; Peritonitis; Quinazolines; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Structure-Activity Relationship; Thiadiazines | 2000 |
Synthesis and pharmacological study of ethyl 1-methyl-5-(substituted 3,4-dihydro-4-oxoquinazolin-3-yl)-1H-pyrazole-4-acetates.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Benzoquinones; Edema; Lethal Dose 50; Magnetic Resonance Spectroscopy; Male; Mice; Peritonitis; Pyrazoles; Quinazolines; Rats; Rats, Sprague-Dawley; Spectrophotometry, Infrared; Stomach Ulcer | 2001 |
Novel quinazoline derivatives. II. A new anti-inflammatory agent, SL-512.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Arthritis; Capillary Permeability; Cyclopropanes; Edema; Erythema; Granuloma; Guinea Pigs; Intestinal Perforation; Lethal Dose 50; Male; Mefenamic Acid; Mice; Peritonitis; Phenylbutazone; Quinazolines; Rats | 1973 |